Twist Bioscience and Berry Genomics to Offer New NGS Solution to Advance Research and Precision Medicine
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Berry Genomics, a